These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 15747743

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
    Gündüz K, Shields CL, Shields JA, Meadows AT, Gross N, Cater J, Needle M.
    Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
    [Abstract] [Full Text] [Related]

  • 23. Regression patterns in treated retinoblastoma with chemotherapy plus focal adjuvant therapy.
    Ghassemi F, Rahmanikhah E, Roohipoor R, Karkhaneh R, Faegh A.
    Pediatr Blood Cancer; 2013 Apr; 60(4):599-604. PubMed ID: 23034769
    [Abstract] [Full Text] [Related]

  • 24. Clinical manifestations and treatment of retinoblastoma in Korea.
    Chung SE, Sa HS, Koo HH, Yoo KH, Sung KW, Ham DI.
    Br J Ophthalmol; 2008 Sep; 92(9):1180-4. PubMed ID: 18650212
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Retinoblastoma regression patterns and results following chemo reduction and adjuvant therapy].
    Xue K, Qian J, Yue H, Yuan YF, Zhang R.
    Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):625-30. PubMed ID: 22943868
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors.
    Shields CL, Palamar M, Sharma P, Ramasubramanian A, Leahey A, Meadows AT, Shields JA.
    Arch Ophthalmol; 2009 Mar; 127(3):282-90. PubMed ID: 19273791
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
    Berry JL, Kogachi K, Aziz HA, McGovern K, Zolfaghari E, Murphree AL, Jubran R, Kim JW.
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
    [Abstract] [Full Text] [Related]

  • 31. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP, Honavar SG, Reddy VA, Khanna R.
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [Abstract] [Full Text] [Related]

  • 32. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.
    Friedman DL, Himelstein B, Shields CL, Shields JA, Needle M, Miller D, Bunin GR, Meadows AT.
    J Clin Oncol; 2000 Jan; 18(1):12-7. PubMed ID: 10623688
    [Abstract] [Full Text] [Related]

  • 33. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors.
    Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B.
    Ophthalmology; 2001 Nov; 108(11):2116-21. PubMed ID: 11713089
    [Abstract] [Full Text] [Related]

  • 34. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
    Murphree AL, Villablanca JG, Deegan WF, Sato JK, Malogolowkin M, Fisher A, Parker R, Reed E, Gomer CJ.
    Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
    [Abstract] [Full Text] [Related]

  • 35. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
    Balwierz W, Kobylarz J, Starzycka M, Dluzniewska A.
    Med Wieku Rozwoj; 2001 Nov; 5(3 Suppl 1):15-23. PubMed ID: 12004148
    [Abstract] [Full Text] [Related]

  • 36. Chemoreduction for intraocular retinoblastoma in Malaysia.
    Menon BS, Juraida E, Alagaratnam J, Mohammad M, Ibrahim H, George TM, Ariffin H, Ho C, Khuzaiah R, Peng LH.
    J Pediatr Hematol Oncol; 2007 Jan; 29(1):2-4. PubMed ID: 17230058
    [Abstract] [Full Text] [Related]

  • 37. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma].
    Kobylarz J, Piwowarczyk A, Romanowska-Dixon B, Balwierz W, Dłuzniewska A.
    Klin Oczna; 2006 Jan; 108(1-3):55-9. PubMed ID: 16883942
    [Abstract] [Full Text] [Related]

  • 38. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH.
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [Abstract] [Full Text] [Related]

  • 39. Retinocytoma shows lack of response to chemoreduction.
    Chung J, Turaka K, Shields CL.
    J Pediatr Ophthalmol Strabismus; 2010 Dec 22; 47 Online():e1-3. PubMed ID: 21175116
    [Abstract] [Full Text] [Related]

  • 40. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C, Wilson MW, Haik BG, Merchant TE, Billups CA, Shah N, Cain A, Langston J, Lipson M, Kun LE, Pratt CB.
    J Clin Oncol; 2003 May 15; 21(10):2019-25. PubMed ID: 12743157
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.